XOMA Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Preferred stock 8.625% Series A Cumulative, Perpetual Preferred Stock	Preferred stock 8.375% Series B Cumulative, Perpetual Preferred Stock	Preferred stock Convertible preferred stock.	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019				$ 73	$ 1,238,299	$ (1,194,384)	$ 43,988
Balance (in shares) at Dec. 31, 2019			6,000	9,759,000
Increase (Decrease) in Stockholders' Equity
Issuance of common stock related to 401(k) contribution					88		88
Issuance of common stock related to 401(k) contribution (in shares)				3,000
Stock-based compensation expense					1,788		1,788
Disgorgement of stockholder's short-swing profits					13		13
Net loss						(4,758)	(4,758)
Balance at Mar. 31, 2020				$ 73	1,240,188	(1,199,142)	41,119
Balance (in shares) at Mar. 31, 2020			6,000	9,762,000
Balance at Dec. 31, 2019				$ 73	1,238,299	(1,194,384)	43,988
Balance (in shares) at Dec. 31, 2019			6,000	9,759,000
Increase (Decrease) in Stockholders' Equity
Net loss							(8,291)
Balance at Jun. 30, 2020				$ 83	1,240,987	(1,202,675)	38,395
Balance (in shares) at Jun. 30, 2020			5,000	11,018,000
Balance at Mar. 31, 2020				$ 73	1,240,188	(1,199,142)	41,119
Balance (in shares) at Mar. 31, 2020			6,000	9,762,000
Increase (Decrease) in Stockholders' Equity
Exercise of stock options					10		10
Exercise of stock options (in shares)				2,000
Issuance of common stock related to ESPP					26		26
Issuance of common stock related to ESPP (in shares)				1,000
Stock-based compensation expense					773		773
Issuance of common stock related to Series Y preferred stock conversion				$ 10	(10)
Issuance of common stock related to Series Y preferred stock conversion (in shares)			(1,000)	1,253,000
Net loss						(3,533)	(3,533)
Balance at Jun. 30, 2020				$ 83	1,240,987	(1,202,675)	38,395
Balance (in shares) at Jun. 30, 2020			5,000	11,018,000
Balance at Dec. 31, 2020	$ 49			$ 84	1,267,377	(1,181,086)	86,424
Balance (in shares) at Dec. 31, 2020	984,000		5,000	11,229,000
Increase (Decrease) in Stockholders' Equity
Exercise of stock options					388		388
Exercise of stock options (in shares)				24,000
Exercise of common stock warrants (in shares)				5,000
Issuance of common stock related to 401(k) contribution					90		90
Issuance of common stock related to 401(k) contribution (in shares)				2,000
Stock-based compensation expense					2,898		2,898
Preferred stock dividends					(707)		(707)
Net loss						(7,373)	(7,373)
Balance at Mar. 31, 2021	$ 49			$ 84	1,270,046	(1,188,459)	81,720
Balance (in shares) at Mar. 31, 2021	984,000		5,000	11,260,000
Balance at Dec. 31, 2020	$ 49			$ 84	1,267,377	(1,181,086)	$ 86,424
Balance (in shares) at Dec. 31, 2020	984,000		5,000	11,229,000
Increase (Decrease) in Stockholders' Equity
Exercise of stock options (in shares)							73,575
Net loss							$ (9,610)
Balance at Jun. 30, 2021	$ 49			$ 85	1,307,140	(1,190,696)	116,578
Balance (in shares) at Jun. 30, 2021	984,000	2,000	5,000	11,310,000
Balance at Mar. 31, 2021	$ 49			$ 84	1,270,046	(1,188,459)	81,720
Balance (in shares) at Mar. 31, 2021	984,000		5,000	11,260,000
Increase (Decrease) in Stockholders' Equity
Exercise of stock options				$ 1	593		594
Exercise of stock options (in shares)				49,000
Issuance of common stock related to ESPP					17		17
Issuance of common stock related to ESPP (in shares)				1,000
Stock-based compensation expense					768		768
Issuance of stock					37,140		37,140
Issuance of stock, net (in shares)		2,000
Preferred stock dividends					(1,424)		(1,424)
Net loss						(2,237)	(2,237)
Balance at Jun. 30, 2021	$ 49			$ 85	$ 1,307,140	$ (1,190,696)	$ 116,578
Balance (in shares) at Jun. 30, 2021	984,000	2,000	5,000	11,310,000